Stocks
Asensus Surgical (ASXC) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | ||||
| R&D/CAPEX, % | 2 263% | 2 263% | 6 599% | 6 599% | 12 821% | ||||
| Changes by years, y/y, % | -1 414pp | 0pp | +4 337pp | 0pp | +18.4% | ||||
Asensus Surgical. R&D/CAPEX, %
Asensus Surgical. R&D/CAPEX, changes, pp
Asensus Surgical (ASXC) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D/CAPEX, % | 2 885% | 11 800% | 11 800% | 6 875% | 12 821% | |||
| Changes by years, y/y, % | +1 423pp | +9 528pp | +9 528pp | -15 842pp | -1 929pp | |||
| Changes by quarters, q/q, % | -5 919pp | +8 915pp | 0pp | -11 800pp | ||||
